Table:
begin	end	state
1	24	cytoplasmic
25	46	transmembrane
47	60	non-cytoplasmic
61	86	transmembrane
87	97	cytoplasmic
98	119	transmembrane
120	120	non-cytoplasmic
121	121	transmembrane
122	124	non-cytoplasmic
125	151	transmembrane
152	164	cytoplasmic
165	185	transmembrane
186	196	non-cytoplasmic
197	216	transmembrane
217	250	cytoplasmic
251	269	transmembrane
270	288	non-cytoplasmic
289	306	transmembrane
307	317	cytoplasmic
318	339	transmembrane
340	346	non-cytoplasmic
347	368	transmembrane
369	380	cytoplasmic
381	402	transmembrane
403	412	non-cytoplasmic
413	432	transmembrane
433	449	cytoplasmic

Input:
>H281DRAFT_04512
MQTVMQAVTPAAAAPPLSRSQMRRAVLASVIGNGLEWFDFLIYGYFAKVIAQVYFPANNS
FVSITLTLATFAIGFLVRPLGGIVIGACADRYGRRKTLSLLILLMALSTLMMGLTPGYAT
IGIAAPLIVIVARILQGLSVGGEFATAAAMLTEYAPPRRKMFFGSFQMTSQAVALLLSSL
CALLLTTRLSHESLVSWGWRVPFLLGALVGPVGFYIRHKVGESPEFLQLRERLGHAPRQS
LRTFIRERGDAALCAMGVIIVGAATNYLWHSYMPLYVEHQLHLPLKNALFGTAISGLIGI
AGYPLAGRLADRFGAYRLFFPVAIAWVCVAYPLFAWVLAAPSAERVFTAQMIATVVLSLM
SGAHPGMLTQLFPTSTRSTGVALSYNVAVTLFGGLAPLTVSTLIDVTGSRLVPAWYLICA
GVISLLLVGLTASGRRLVRKPDLWLADGQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server